Evaluation of trifluperidol in chronic schizaphrenia.
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002090:Butyrophenones / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D005461:Fluorine / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use*; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy*; D014272:Trifluperidol / Q000627:therapeutic use
D000928:Antidepressive Agents; D002090:Butyrophenones; D010880:Piperidines; D010919:Placebos; D005461:Fluorine; D014272:Trifluperidol; D002746:Chlorpromazine